|
Volumn 380, Issue 1, 2016, Pages 203-204
|
Targeting tumor microenvironment in cancer therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOENGINEERING;
BLOOD CELL;
BONE MARROW CELL;
BONE MARROW METASTASIS;
BREAST CANCER;
CANCER CELL;
CANCER GROWTH;
CANCER STEM CELL;
CANCER THERAPY;
CELL MOTILITY;
CELL PROLIFERATION;
CELL SUBPOPULATION;
CELL SURVIVAL;
CELLS BY BODY ANATOMY;
CLASSICAL HODGKIN LYMPHOMA;
EDITORIAL;
EPITHELIAL MESENCHYMAL TRANSITION;
IMMUNE RESPONSE;
IMMUNOCOMPETENT CELL;
METABOLIC REGULATION;
METASTASIS POTENTIAL;
MULTIPLE MYELOMA;
NEUROBLASTOMA;
PRIMARY TUMOR;
PRIORITY JOURNAL;
STEM CELL NICHE;
STROMA CELL;
SUPPRESSOR CELL;
TUMOR IMMUNITY;
TUMOR MICROENVIRONMENT;
TUMOR VASCULARIZATION;
ANIMAL;
DRUG EFFECTS;
HUMAN;
METABOLISM;
MOLECULARLY TARGETED THERAPY;
NEOPLASMS;
PATHOLOGY;
SIGNAL TRANSDUCTION;
ANTINEOPLASTIC AGENT;
ANIMALS;
ANTINEOPLASTIC AGENTS;
HUMANS;
MOLECULAR TARGETED THERAPY;
NEOPLASMS;
SIGNAL TRANSDUCTION;
TUMOR MICROENVIRONMENT;
|
EID: 84962786857
PISSN: 03043835
EISSN: 18727980
Source Type: Journal
DOI: 10.1016/j.canlet.2016.04.009 Document Type: Editorial |
Times cited : (44)
|
References (0)
|